A Phase II Trial of Loncastuximab Tesirine for Relapsed/Refractory Large B-cell Lymphoma After CAR T-cell Therapy
M.D. Anderson Cancer Center
Why this is shown: Actively enrolling · PHASE2 · 1 site in TX
Showing 1–24 of 61 trials
M.D. Anderson Cancer Center
Why this is shown: Actively enrolling · PHASE2 · 1 site in TX
CRISPR Therapeutics AG
Why this is shown: Actively enrolling · Phase 1/2 · 4 sites in KS, MO, TX +1
Janssen Research & Development, LLC
Why this is shown: Actively enrolling · Phase 1/2 · 14 sites in CA, CO, IA +8
Danielle Wallace
Why this is shown: Actively enrolling · PHASE2 · 1 site in NY
Acepodia Biotech, Inc.
Why this is shown: Actively enrolling · PHASE1 · 5 sites in FL, GA, IN +2
Stanford University
Why this is shown: Actively enrolling · PHASE1 · 1 site in CA
Abramson Cancer Center at Penn Medicine
Why this is shown: Actively enrolling · PHASE2 · 2 sites in NE, PA
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Why this is shown: Actively enrolling · PHASE2 · 17 sites in CA, FL, GA +8
City of Hope Medical Center
Why this is shown: Actively enrolling · 1 site in CA
Joshua Sasine, MD, PhD
Why this is shown: Actively enrolling · PHASE1 · 1 site in CA
City of Hope Medical Center
Why this is shown: Actively enrolling · PHASE2 · 1 site in CA
Bantam Pharmaceuticals
Why this is shown: Actively enrolling · PHASE1 · 1 site in TX
Lyell Immunopharma, Inc.
Why this is shown: Actively enrolling · Phase 1/2 · 30 sites in CA, CO, GA +16
Schrödinger, Inc.
Why this is shown: Actively enrolling · PHASE1 · 16 sites in AZ, DE, FL +10
Verismo Therapeutics
Why this is shown: Actively enrolling · PHASE1 · 5 sites in CO, GA, KS +2
H. Lee Moffitt Cancer Center and Research Institute
Why this is shown: Actively enrolling · PHASE2 · 1 site in FL
Step Pharma, SAS
Why this is shown: Actively enrolling · Phase 1/2 · 3 sites in CO, FL, NY
AstraZeneca
Why this is shown: Actively enrolling · Phase 1/2 · 12 sites in MA, NC, NJ +6
Nurix Therapeutics, Inc.
Why this is shown: Actively enrolling · PHASE1 · 18 sites in CA, CO, CT +11
Jennifer Amengual
Why this is shown: Actively enrolling · PHASE2 · 2 sites in CA, NY
Estrella Biopharma, Inc.
Why this is shown: Actively enrolling · Phase 1/2 · 2 sites in CA, TX
SWOG Cancer Research Network
Why this is shown: Actively enrolling · PHASE2 · 87 sites in AR, AZ, CA +24
Vironexis Biotherapeutics Inc.
Why this is shown: Actively enrolling · Phase 1/2 · 9 sites in CA, CO, NC +5
C. Babis Andreadis
Why this is shown: Actively enrolling · PHASE1 · 1 site in CA